HWAM
XLRN

Hennion & Walsh Asset Management’s Acceleron Pharma XLRN Stock Holding History

Hennion & Walsh Asset Management’s Portfolio XLRN Stock Details XLRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-22,685
Closed -$3.9M – 799
2021
Q3 		$3.9M Sell
22,685
-979
-4% -$128K 0.21% 135
2021
Q2 		$2.97M Buy
23,664
+54
+0.2% +$6.81K 0.16% 184
2021
Q1 		$3.2M Buy
+23,610
New +$3.05M 0.19% 144

Hennion & Walsh Asset Management's XLRN Position: Q4 2021 in Review

Hennion & Walsh Asset Management sold out of Acceleron Pharma (XLRN) in Q4 2021, closing a stake of 22,685 shares — an estimated $3.9M sold.

Hennion & Walsh Asset Management first reported a position in XLRN in Q1 2021 and held it in 3 quarters. The position peaked at $3.9M in Q3 2021. 1 fund tracked by Wall St. Rank holds XLRN as of Q4 2021.

  • Hennion & Walsh Asset Management reported no remaining Acceleron Pharma position as of Q4 2021 after selling out during the quarter.
  • Hennion & Walsh Asset Management sold 22,685 Acceleron Pharma shares in Q4 2021, an estimated $3.9M.
  • Hennion & Walsh Asset Management first reported a position in Acceleron Pharma in Q1 2021 and held it in 3 quarters.
  • Hennion & Walsh Asset Management's Acceleron Pharma position peaked at $3.9M in Q3 2021.
  • 1 fund tracked by Wall St. Rank held Acceleron Pharma as of Q4 2021.

Based on Hennion & Walsh Asset Management's 13F filing for Q4 2021, filed 14 Feb 2022.